Seizert Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,165
| Closed | -$1.68M | – | 177 |
|
|
2024
Q4 | $1.68M | Sell |
4,165
-6,546
| -61% | -$2.64M | 0.08% | 111 |
|
|
2024
Q3 | $4.98M | Buy |
10,711
+20
| +0.2% | +$9.3K | 0.22% | 81 |
|
|
2024
Q2 | $5.01M | Sell |
10,691
-1,466
| -12% | -$687K | 0.25% | 71 |
|
|
2024
Q1 | $5.08M | Sell |
12,157
-415
| -3% | -$173K | 0.23% | 72 |
|
|
2023
Q4 | $5.12M | Sell |
12,572
-4,823
| -28% | -$1.96M | 0.26% | 71 |
|
|
2023
Q3 | $6.05M | Sell |
17,395
-335
| -2% | -$116K | 0.32% | 59 |
|
|
2023
Q2 | $6.24M | Sell |
17,730
-11,069
| -38% | -$3.9M | 0.33% | 60 |
|
|
2023
Q1 | $9.07M | Sell |
28,799
-7,582
| -21% | -$2.39M | 0.5% | 52 |
|
|
2022
Q4 | $10.5M | Sell |
36,381
-3,438
| -9% | -$993K | 0.56% | 48 |
|
|
2022
Q3 | $11.5M | Sell |
39,819
-165
| -0.4% | -$47.8K | 0.65% | 46 |
|
|
2022
Q2 | $11.3M | Sell |
39,984
-94
| -0.2% | -$26.5K | 0.6% | 46 |
|
|
2022
Q1 | $10.5M | Buy |
40,078
+1,480
| +4% | +$386K | 0.48% | 53 |
|
|
2021
Q4 | $8.48M | Buy |
38,598
+3,640
| +10% | +$799K | 0.38% | 62 |
|
|
2021
Q3 | $6.34M | Buy |
34,958
+1
| +0% | +$181 | 0.29% | 64 |
|
|
2021
Q2 | $7.05M | Buy |
34,957
+1,098
| +3% | +$221K | 0.34% | 64 |
|
|
2021
Q1 | $7.28M | Buy |
+33,859
| New | +$7.28M | 0.38% | 65 |
|